Taiyen Biotech CoTPE:1737 83 Gross Margin % is 39.54% as of Dec. 2025, which is 3% below its 10-year median of 40.70. GuruFocus rates TPE:1737 with a GF Score™ of 83/100 and a GF Value™ of NT$32.09 (Fairly Valued). The stock has 1 warning sign investors should review. Among 1,898 Consumer Packaged Goods companies, Taiyen Biotech Co ranks better than 76.45% on this metric.
The historical rank and industry rank for Taiyen Biotech Co's Gross Margin % or its related term are showing as below:
TPE:1737'
s Gross Margin % Range Over the Past 10 Years
Min: 33.53 Med: 40.7 Max: 41.77
Current: 40.6
During the past 13 years, the highestGross Margin % of Taiyen Biotech Co was 41.77%. The lowest was 33.53%. And the median was 40.70%.
TPE:1737's Gross Margin % is ranked better than 76.45% of 1898
companies
in the Consumer Packaged Goods industry
Industry Median: 26.355
vs TPE:1737: 40.60
Taiyen Biotech Co had a gross margin of 39.54% for the quarter that ended in Dec. 2025 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Taiyen Biotech Co was 1.40% per year.
Taiyen Biotech Co (TPE:1737) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Taiyen Biotech Co had a gross margin of 39.54% for the quarter that ended in Dec. 2025 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Taiyen Biotech Co Gross Margin % Related Terms
Taiyen Biotech Co Gross Margin % Historical Data
* Premium members only.
The historical data trend for Taiyen Biotech Co's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:1737 vs PG, CL, KVUE: Gross Margin % Comparison
For the Household & Personal Products subindustry, Taiyen Biotech Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Taiyen Biotech Co Gross Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Taiyen Biotech Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Taiyen Biotech Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Taiyen Biotech Co (TPE:1737) has a Gross Margin % of 39.54% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Taiyen Biotech Co and its competitors. This is near median its historical median of 40.70. Over the past decade, Taiyen Biotech Co's Gross Margin % has ranged from 33.53 to 41.77. According to the industry distribution chart, Taiyen Biotech Co ranks #447 out of 1898 companies in the Consumer Packaged Goods industry, placing it in the top 23.6%.
Is Taiyen Biotech Co's Gross Margin % too high?
Taiyen Biotech Co's current Gross Margin % of 39.54% is near median its 10-year median of 40.70. Over the past 10 years, this metric has ranged from a low of 33.53 to a high of 41.77. The Consumer Packaged Goods industry median Gross Margin % is 26.36. Taiyen Biotech Co's value of 39.54% is 50% above this industry median. Based on the distribution chart, Taiyen Biotech Co ranks #447 out of 1898 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Taiyen Biotech Co has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Taiyen Biotech Co's Gross Margin % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Taiyen Biotech Co ranks #447 out of 1898 companies for Gross Margin %. This places Taiyen Biotech Co in the top 24% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 26.36. Taiyen Biotech Co's value of 39.54% is 50% above this benchmark. Historically, Taiyen Biotech Co's own Gross Margin % has ranged from 33.53 to 41.77 over the past decade. While the company's 10-year median is 40.70 vs. the industry median of 26.36, Taiyen Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Consumer Packaged Goods company?
The median Gross Margin % among Consumer Packaged Goods companies is 26.36, based on 1,898 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Taiyen Biotech Co's current Gross Margin % of 39.54% is 50% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Taiyen Biotech Co and its competitors. For the Consumer Packaged Goods industry, the median Gross Margin % is 26.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Taiyen Biotech Co's current Gross Margin % is 39.54%, which is near median its own 10-year median of 40.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Taiyen Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Taiyen Biotech Co (TPE:1737) is currently considered Fairly Valued. The stock's GF Value™ is NT$32.09, compared to a current price of NT$31.90 — trading 0.6% below its estimated fair value. The current Gross Margin % is 39.54%, which is near median its 10-year median of 40.70 and 50% above the Consumer Packaged Goods industry median of 26.36. Taiyen Biotech Co's overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Taiyen Biotech Co (TPE:1737), the current Gross Margin % is 39.54% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Taiyen Biotech Co (TPE:1737) Overvalued in 2026?
Based on GuruFocus' analysis, Taiyen Biotech Co stock appears to be undervalued.
The current stock price of NT$31.90 is trading 0.6% below its estimated GF Value™ of NT$32.09.
GuruFocus considers Taiyen Biotech Co to be Fairly Valued.
Key valuation signals for TPE:1737:
Gross Margin %: 39.54% (near median its 10-year median of 40.70)
GF Value™: NT$32.09 vs. price of NT$31.90 (0.6% below fair value)
Industry Position: 50% above the Consumer Packaged Goods median (#447 of 1898)
No single metric tells the full story. See the TPE:1737 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Taiyen Biotech Co Ltd operates in personal care and home care products. Its product portfolio comprises beauty care products, health food, skin products, salt products and spices, bottled water, and medical supplies, among others. The group has four reportable segments; Salt products and packaged water department, Biotech cleaning and maintenance department, Construction and services department, and Other departments.. The Salt and Packaged Product Segment accounts for the bulk of revenue. Geographically it operates through the region of Taiwan; however, it also holds a presence in the international market.
83GF Score
Get the complete analysis for TPE:1737
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1737 has been successfully added to your 
